Cargando…

Metastatic Pancreatic Cancer Is Dependent on Oncogenic Kras in Mice

Pancreatic cancer is one of the deadliest human malignancies, and its prognosis has not improved over the past 40 years. Mouse models that spontaneously develop pancreatic adenocarcinoma and mimic the progression of the human disease are emerging as a new tool to investigate the basic biology of thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Collins, Meredith A., Brisset, Jean-Christophe, Zhang, Yaqing, Bednar, Filip, Pierre, Josette, Heist, Kevin A., Galbán, Craig J., Galbán, Stefanie, di Magliano, Marina Pasca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513322/ https://www.ncbi.nlm.nih.gov/pubmed/23226501 http://dx.doi.org/10.1371/journal.pone.0049707

Ejemplares similares

Kras as a key oncogene and therapeutic target in pancreatic cancer
por: Collins, Meredith A., et al.
Publicado: (2014)

Fbxw7 Deletion Accelerates Kras(G12D)-Driven Pancreatic Tumorigenesis via Yap Accumulation()()()
por: Zhang, Qiang, et al.
Publicado: (2016)

ATDC induces an invasive switch in KRAS-induced pancreatic tumorigenesis
por: Wang, Lidong, et al.
Publicado: (2015)

Lung cancer lesion detection in histopathology images using graph‐based sparse PCA network()
por: Ram, Sundaresh, et al.
Publicado: (2023)

Tyrosine Sulfation: A New Player and Potential Target in Pancreatic Cancer
por: Zhang, Yaqing, et al.
Publicado: (2023)

Integrated Multimodal Imaging of Dynamic Bone-Tumor Alterations Associated with Metastatic Prostate Cancer
por: Brisset, Jean-Christophe, et al.
Publicado: (2015)

Therapeutic Potential of Targeting Stromal Crosstalk-Mediated Immune Suppression in Pancreatic Cancer
por: Du, Wenting, et al.
Publicado: (2021)

Immune cells in pancreatic cancer: Joining the dark side
por: Zhang, Yaqing, et al.
Publicado: (2014)

Oncogenic KRAS signalling in pancreatic cancer
por: Eser, S, et al.
Publicado: (2014)

Extrinsic KRAS Signaling Shapes the Pancreatic Microenvironment Through Fibroblast Reprogramming
por: Velez-Delgado, Ashley, et al.
Publicado: (2022)

Evaluation of Concurrent Radiation, Temozolomide and ABT-888 Treatment Followed by Maintenance Therapy with Temozolomide and ABT-888 in a Genetically Engineered Glioblastoma Mouse Model
por: Lemasson, Benjamin, et al.
Publicado: (2016)

Differential Contribution of Pancreatic Fibroblast Subsets to the Pancreatic Cancer Stroma
por: Garcia, Paloma E., et al.
Publicado: (2020)

Early pancreatic islet fate and maturation is controlled through RBP-Jκ
por: Cras-Méneur, Corentin, et al.
Publicado: (2016)

Epithelial Notch signaling is a limiting step for pancreatic carcinogenesis
por: Thomas, Marsha M, et al.
Publicado: (2014)

DW-MRI as a Biomarker to Compare Therapeutic Outcomes in Radiotherapy Regimens Incorporating Temozolomide or Gemcitabine in Glioblastoma
por: Galbán, Stefanie, et al.
Publicado: (2012)

MRI-Guided Stereotactic Biopsy of Murine GBM for Spatiotemporal Molecular Genomic Assessment
por: Galbán, Stefanie, et al.
Publicado: (2017)

ATDC is required for the initiation of KRAS-induced pancreatic tumorigenesis
por: Wang, Lidong, et al.
Publicado: (2019)

3373 Modulation of Hedgehog Signaling Alters Immune Infiltration in Pancreatic Cancer
por: Steele, Nina, et al.
Publicado: (2019)

Pancreatic Tumorigenesis: Oncogenic KRAS and the Vulnerability of the Pancreas to Obesity
por: Luo, Yongde, et al.
Publicado: (2021)

The Gustatory Sensory G-Protein GNAT3 Suppresses Pancreatic Cancer Progression in Mice
por: Hoffman, Megan T., et al.
Publicado: (2020)

Exosomes Facilitate Therapeutic Targeting of Oncogenic Kras in Pancreatic Cancer
por: Kamerkar, Sushrut, et al.
Publicado: (2017)

Notch signaling regulates immunosuppressive tumor-associated macrophage function in pancreatic cancer
por: Yan, Wei, et al.
Publicado: (2023)

Semiautomated Workflow for Clinically Streamlined Glioma Parametric Response Mapping
por: Keith, Lauren, et al.
Publicado: (2016)

Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis
por: Santana-Codina, Naiara, et al.
Publicado: (2018)

Differential Effects of Dietary Macronutrients on the Development of Oncogenic KRAS-Mediated Pancreatic Ductal Adenocarcinoma
por: Zhu, Liang, et al.
Publicado: (2022)

Kras(G12D) induces changes in chromatin territories that differentially impact early nuclear reprogramming in pancreatic cells
por: Mathison, Angela J., et al.
Publicado: (2021)

RAGE is essential for oncogenic KRAS-mediated hypoxic signaling in pancreatic cancer
por: Kang, R, et al.
Publicado: (2014)

Myeloid Cell Mediated Ilmmune Suppression in Pancreatic Cancer
por: Kemp, Samantha B., et al.
Publicado: (2021)

Epithelial-Myeloid cell crosstalk regulates acinar cell plasticity and pancreatic remodeling in mice
por: Zhang, Yaqing, et al.
Publicado: (2017)

Arachnoid diverticulum diagnosis following treatment of cryptococcal meningitis in a dog
por: Galban, Evelyn, et al.
Publicado: (2018)

Loss of Jag1 cooperates with oncogenic Kras to induce pancreatic cystic neoplasms
por: Chung, Wen-Cheng, et al.
Publicado: (2020)

KRAS as a Key Oncogene in the Clinical Precision Diagnosis and Treatment of Pancreatic Cancer
por: Dai, Manxiong, et al.
Publicado: (2022)

Mitogen-activated Protein Kinase Kinase Activity Maintains Acinar-to-Ductal Metaplasia and Is Required for Organ Regeneration in Pancreatitis
por: Halbrook, Christopher J., et al.
Publicado: (2016)

Potential for Early Fracture Risk Assessment in Patients with Metastatic Bone Disease Using Parametric Response Mapping of CT Images
por: Hoff, Benjamin A., et al.
Publicado: (2015)

Combinatorial Gli activity directs immune infiltration and tumor growth in pancreatic cancer
por: Scales, Michael K., et al.
Publicado: (2022)

USP21 deubiquitinase elevates macropinocytosis to enable oncogenic KRAS bypass in pancreatic cancer
por: Hou, Pingping, et al.
Publicado: (2021)

Arginase 1 is a key driver of immune suppression in pancreatic cancer
por: Menjivar, Rosa E, et al.
Publicado: (2023)

Pancreatic Fibroblast Heterogeneity: From Development to Cancer
por: Garcia, Paloma E., et al.
Publicado: (2020)

Mutant p53(R270H) drives altered metabolism and increased invasion in pancreatic ductal adenocarcinoma
por: Schofield, Heather K., et al.
Publicado: (2018)

CT-based Biomarker Provides Unique Signature for Diagnosis of COPD Phenotypes and Disease Progression
por: Galbán, Craig J., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ov6lmcu0msuvg9jra4sfoqsjo2